This Medicines and Healthcare products Regulatory Agency (MHRA) guidance is for those who want to manufacture, import, distribute or supply unlicensed medicines for human use (also known as ‘specials’), including CBPMs.

‘Specials’ are products which have been specially manufactured or imported for the treatment of an individual patient after being ordered by a:

Persons authorised to procure unlicensed CBPMs in the UK are: